Global Solid Tumors Treatment Market - Opportunity Analysis, 2017–2025

1
(No Transcript)
2

• REPORT DESCRIPTION

Solid Tumors Treatment Market Overview A solid
tumor is an abnormal mass or lump of tissues
without liquid or cysts. It is not necessary that
tumor should always be cancerous. On the basis
tumor nature, it can be classified as the
malignant tumor (cancerous) and the benign tumor
(non-cancerous). Based on the cell type, tumors
can be classified as carcinomas, sarcomas, and
lymphomas. The Solid tumors might occur in
several places such as muscle, bone, and organs.
Treatments for solid tumors include prevention of
tumor and combination of surgery, chemotherapy,
and radiation therapy. However, new forms of
treatment are emerging in the market. Emerging
trend of Biosimilars therapy is expected to
propel the growth of solid tumors treatment
market According to data published in
International Journal of Pharma Sciences and
Research (IJPSR) in 2011, there were around 9
million deaths due to cancer. In 2015, 11.4
million people are expected to die in 2030, among
this prevalence of cancer maximum is due to solid
tumors. Growing prevalence of solid tumors is the
major driving factor for the growth of solid
tumors treatment market. Additionally, some other
factors fuelling the growth of solid tumors
treatment market include unmet demand for cancer
treatment and rising investment in the research
and development of cancer drugs.  However,
increase in the volume of generic therapeutic
products, the high cost of cancer therapy, and
growing drug patent cliff are some of the
restraints that might hinder the growth of solid
tumors treatment market. Moreover, the emerging
trend of biosimilars is contributing to the
growth of solid tumors treatment market due to
their low cost and their similarity to originator
compound. For instance, some of the biologics
available for solid tumors treatment includes
Herceptin, MabThera, Avastin, and Erbitux. The
advantages of this biosimilars to overcome the
limitations of generic drugs in the treatments is
expected to propel the growth of solid tumors
treatments market.
3
REPORT DESCRIPTION
Solid Tumors Treatment Market Taxonomy  On the
basis of therapy, solid tumors treatment
market is segmented into Radiotherapy Chemotherap
y Immunotherapy Hormone therapy Targeted
therapy On the basis of application, solid tumors
treatment market is segmented into Lung
cancer Breast cancer Prostate cancer Cervical
cancer Colorectal cancer Others On the basis of
end users, solid tumors treatment market is
segmented into Hospitals Cancer treatment
centers To get holistic SAMPLE of the report
including table of contents, please click
https//www.coherentmarketinsights.com/insight/req
uest-sample/793
4
REPORT DESCRIPTION

• Solid Tumors Treatment Market Key Players
• Major players involved in the global solid tumors
  treatment market include
• Abbott Laboratories Inc.
• Biogen Idec Incorporated
• AstraZeneca Plc.
• Johnson Johnson Company
• Amgen Inc.
• Bristol Myers Squibb Company
• GlaxoSmithKline Plc.
• Sanofi
• Baxter International Incorporated
• Click here to know more about this report
  https//www.coherentmarketinsights.com/ongoing-ins
  ight/solid-tumors-treatment-market-793

5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
THANK YOU
To know more about us, visit our website
www.coherentmarketinsights.com For sales
queries or new topics email us on
sales_at_coherentmarketinsights.com For other
queries contact Mr. Shah (Manager - Business Deve
lopment) Coherent Market Insights sales_at_coherentm
arketinsights.com 1-206-701-6702